4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate has been researched along with Acute Disease in 13 studies
*Acute Disease: Disease having a short and relatively severe course. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 11 (84.62) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T; Ishiguro, H; Kitagawa, M; Kondo, T; Nakae, Y; Sakai, Y; Shibata, T; Sobajima, H; Tanikawa, M | 1 |
| Ando, K; Furuyama, H; Hirano, T; Kawakami, Y; Tsuchitani, T | 1 |
| Atomi, Y; Kimura, W; Kuroda, A; Mineo, C; Muto, T; Sata, N | 1 |
| Ha, SS; Hiura, A; Nishiwaki, H; Satake, K | 1 |
| Ha, SS; Hiura, A; Ko, I; Nishiwaki, H; Satake, K; Sowa, M | 1 |
| Hirano, T; Manabe, T; Nio, Y; Ohshio, G; Yotsumoto, F | 1 |
| Hirano, T; Manabe, T | 2 |
| Hirano, T; Manabe, T; Nio, Y; Ohshio, G | 1 |
| Hirano, T; Imanishi, K; Kyogoku, T; Manabe, T; Tobe, T; Yotsumoto, F | 1 |
| Ha, SS; Hiura, A; Nishiwaki, H; Satake, K; Umeyama, K | 1 |
| Hiura, A; Nishiwaki, H; Satake, K; Umeyama, K | 1 |
| Hishinuma, I; Miyamoto, K; Nagakawa, J; Nagaoka, N; Wakabayashi, T; Yamanaka, T | 1 |
13 other study(ies) available for 4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate and Acute Disease
| Article | Year |
|---|---|
Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis.
Topics: Acute Disease; alpha-Macroglobulins; Animals; Dose-Response Relationship, Drug; Guanidines; Injections, Subcutaneous; Male; Monitoring, Physiologic; Pancreatitis; Rats; Rats, Wistar; Trypsin; Trypsin Inhibitors | 1994 |
Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Constriction; Drug Therapy, Combination; Guanidines; Ischemia; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Superoxide Dismutase | 1995 |
Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Topics: Acute Disease; alpha-Amylases; Animals; Cathepsin B; Ceruletide; Edema; Guanidines; Male; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Subcellular Fractions; Trypsin; Vacuoles | 1994 |
The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Topics: Acute Disease; Animals; beta-Endorphin; Blood Flow Velocity; Blood Pressure; Cardiac Output; Dogs; Female; Guanidines; Hemodynamics; Male; Pancreatitis; Renal Artery; Serine Proteinase Inhibitors | 1993 |
Renal microcirculation in experimental acute pancreatitis of dogs.
Topics: Acute Disease; Acute Kidney Injury; Animals; Dogs; Guanidines; Microcirculation; Pancreatitis; Renal Circulation; Serine Proteinase Inhibitors | 1993 |
Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
Topics: Acute Disease; Amylases; Animals; Bile Ducts; Cathepsin B; Constriction; Guanidines; Lysosomes; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors | 1992 |
Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Topics: Acute Disease; Animals; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Guanidines; Male; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Taurocholic Acid | 1992 |
A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Topics: Acute Disease; Amylases; Animals; Body Water; Ceruletide; Guanidines; Lysosomes; Male; Mitochondria; Pancreas; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors | 1992 |
Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazole.
Topics: Acute Disease; Animals; Cefmetazole; Chi-Square Distribution; Choline; Drug Therapy, Combination; Ethionine; Female; Food, Formulated; Guanidines; Mice; Mice, Inbred Strains; Pancreatitis; Serine Proteinase Inhibitors; Survival Rate | 1992 |
A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; Guanidines; Male; Organelles; Osmotic Fragility; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors | 1991 |
Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
Topics: Acute Disease; Animals; beta-Endorphin; Dogs; Female; Guanidines; Hemodynamics; Infusions, Intravenous; Lactates; Male; Pancreas; Pancreatitis; Serine Proteinase Inhibitors | 1991 |
Effects of a newly synthesized pancreatic protease inhibitor (PATM) on pancreatic microcirculation in experimental acute pancreatitis.
Topics: Acute Disease; Animals; Dogs; Guanidines; Microcirculation; Pancreas; Pancreatitis; Protease Inhibitors; Regional Blood Flow; Time Factors | 1989 |
[Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Topics: Acute Disease; Animals; Dogs; Dose-Response Relationship, Drug; Female; Guanidines; Lipase; Male; Pancreas; Pancreatitis; Protease Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Trypsin Inhibitors | 1988 |